Correlation Between Financial Toxicity, Quality of Life, and Patient Satisfaction in an Insured Population of Breast Cancer Surgical Patients: A Single-Institution Retrospective Study
- 11 December 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American College of Surgeons
- Vol. 232 (3), 253-263
- https://doi.org/10.1016/j.jamcollsurg.2020.10.023
Abstract
Background The relationship between treatment-related, cost-associated distress “financial toxicity” (FT) and quality-of life (QOL) in breast cancer patients remains poorly characterized. This study leverages validated patient-reported outcomes measures (PROMs) to analyze the association between FT and QOL and satisfaction among women undergoing ablative breast cancer surgery. Study design This is a single-institution cross-sectional survey of all female breast cancer patients (>18 years old) who underwent lumpectomy or mastectomy between January 2018 and June 2019. FT was measured via the 11-item COmprehensive Score for financial Toxicity (COST) instrument. The BREAST-Q and SF-12 were used to asses condition-specific and global QOL, respectively. Responses were linked with demographic and clinical data. Pearson correlation coefficient and multivariable regression were used to examine associations. Results Our analytical sample consisted of 532 patients; mean age 58, mostly white (76.7%), employed (63.7%), married/committed (73.7%), with 64.3% undergoing reconstruction. Median household income was $80,000 to $120,000/year, and mean COST score was 28.0. After multivariable adjustment, a positive relationship for all outcomes was noted; lower COST (greater cost-associated distress) was associated with lower BREAST-Q and SF-12 scores. This relationship was strongest for BREAST-Q psychosocial well-being, for which we observed a 0.89 (95% CI 0.76–1.03) change per unit change in COST score. Conclusions Financial toxicity captured in this study correlates with statistically significant and clinically important differences in BREAST-Q psychosocial well-being, patient satisfaction with reconstructed breasts, and SF-12 global mental and physical quality of life. Treatment costs should be included in the shared decision-making for breast cancer surgery. Future prospective outcomes research should integrate COST.Keywords
Funding Information
- National Academy of Medicine
- Cancer Foundation
- University of Texas MD Anderson Cancer Center
This publication has 40 references indexed in Scilit:
- Projections of the Cost of Cancer Care in the United States: 2010-2020JNCI Journal of the National Cancer Institute, 2011
- Prophylactic mastectomy for the prevention of breast cancerEmergencias, 2010
- Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancerBreast Cancer Research and Treatment, 2010
- Quality of Life Supersedes the Classic Prognosticators for Long-Term Survival in Locally Advanced Non–Small-Cell Lung Cancer: An Analysis of RTOG 9801Journal of Clinical Oncology, 2009
- Development of a New Patient-Reported Outcome Measure for Breast Surgery: The BREAST-QPlastic and Reconstructive Surgery, 2009
- Validation of Patient's Self-Reported Social Functioning As an Independent Prognostic Factor for Survival in Metastatic Colorectal Cancer Patients: Results of an International Study by the Chronotherapy Group of the European Organisation for Research and Treatment of CancerJournal of Clinical Oncology, 2008
- Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.1Health and Quality of Life Outcomes, 2007
- Predicting EuroQoL EQ-5D Preference Scores from the SF-12 Health Survey in a Nationally Representative SampleMedical Decision Making, 2004
- Interpretation of Changes in Health-related Quality of LifeMedical Care, 2003
- A 12-Item Short-Form Health SurveyMedical Care, 1996